Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
Each of 5 drugs, i.e., 4 different vasodilator drugs (captopril, enalapril, hydralazine and prazosin) and a cardiotonic drug (digoxin), was administered to dogs with mitral regurgitation (MR) for 1-72 days in order to quantitatively evaluate the influence of therapeutic agents on blood flow in heart disease. Hemodynamic changes were assessed before and after administration of each drug by determining mitral regurgitant jet mapping area (MRMA) and aortic forward flow mapping area (AFMA), which were displayed by the color Doppler method, and the ratio of MRMA to AFMA (MRMA/AFMA) as parameters. When the four vasodilator drugs were used appropriately, MRMA and MRMA/AFMA decreased in all cases, compared with the values before the administration. These two parameters showed dose-dependent changes after administration of captopril, enalapril and hydralazine. When the cardiotonic drug was used. MRMA and MRMA/AFMA increased in 4 of 5 cases. The MRMA/AFMA values were slightly more reproducible than the MRMA values, whereas the AFMA values showed no constant tendency when any vasodilator drug or the cardiotonic drug was used. These results suggest that the efficacy of cardiotonic and vasodilator drugs in MR can be quantitatively evaluated by determining MRMA/AFMA in particular, and MRMA.
Uehara
Y
Y
Department of Veterinary Surgery, School of Veterinary Medicine, Azabu University, Kanagawa, Japan.
Takahashi
M
M
D000818:Animals; D002216:Captopril / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004283:Dog Diseases; D004285:Dogs; D018618:Echocardiography, Doppler, Color / Q000187:drug effects / Q000662:veterinary; D004656:Enalapril / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006830:Hydralazine / Q000627:therapeutic use; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D006830:Hydralazine; D004656:Enalapril; D004077:Digoxin; D002216:Captopril; D011224:Prazosin